<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0033">
 <element-citation publication-type="journal" id="sbref0033">
  <person-group person-group-type="author">
   <name>
    <surname>Dong-Sheng</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yan-Ping</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Li-Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Shui-Qing</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Chang-Qing</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Qing-Ping</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Artemisinin: A panacea eligible for unrestrictive use?</article-title>
  <source>Frontiers in Pharmacology</source>
  <volume>8</volume>
  <year>2017</year>
  <fpage>737</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2017.00737</pub-id>
  <pub-id pub-id-type="pmid">29089893</pub-id>
 </element-citation>
</ref>
